Your browser doesn't support javascript.
loading
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC).
Dobritoiu, Florin; Baltan, Adelina; Chefani, Alina; Billingham, Kim; Chenard, Marie-Pierrette; Vaziri, Reza; Lacroix-Triki, Magali; Waydelich, Anne; Erb, Gilles; Andersson, Emilia; Cañamero, Marta; Toro, Paula; Wedden, Sarah; D'Arrigo, Corrado.
Afiliación
  • Dobritoiu F; Poundbury Cancer Institute.
  • Baltan A; Department of Pathology, University Emergency Hospital, Bucharest, Romania.
  • Chefani A; Poundbury Cancer Institute.
  • Billingham K; Poundbury Cancer Institute.
  • Chenard MP; Department of Pathology, Great Western Hospital, Swindon, UK.
  • Vaziri R; Département de Pathologie, CHU de Strasbourg, Strasbourg, France.
  • Lacroix-Triki M; Department of Pathology, Worcestershire Acute Hospitals, Worcester, UK.
  • Waydelich A; Département de Pathologie, Gustave Roussy Cancer Campus, Villejuif, France.
  • Erb G; Oncology Medical and Government Affairs Roche Diagnostics EMEA-LATAM Region, Rotkreuz, Switzerland.
  • Andersson E; Global Medical Affairs/PDMA, Roche Basel, Switzerland.
  • Cañamero M; Oncology Medical and Government Affairs Roche Diagnostics EMEA-LATAM Region, Rotkreuz, Switzerland.
  • Toro P; Oncology Medical and Government Affairs Roche Diagnostics EMEA-LATAM Region, Rotkreuz, Switzerland.
  • Wedden S; Clinical Development & Medical Affairs, Roche Diagnostics Solutions, Tucson.
  • D'Arrigo C; CADQAS CIC, Dorchester, UK.
Appl Immunohistochem Mol Morphol ; 30(8): 549-556, 2022 09 01.
Article en En | MEDLINE | ID: mdl-36036647

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Appl Immunohistochem Mol Morphol Asunto de la revista: BIOLOGIA MOLECULAR / HISTOCITOQUIMICA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Appl Immunohistochem Mol Morphol Asunto de la revista: BIOLOGIA MOLECULAR / HISTOCITOQUIMICA Año: 2022 Tipo del documento: Article